ABH Healthcare IPO: Can Anil Baghi Hospital Turn Regional Healthcare Strength Into Its Next Growth Phase?

ABH Healthcare IPO Brings a Hospital Business to the SME Market

Healthcare businesses have a fundamentally different relationship with customers than most other industries.

People can postpone buying a new car, smartphone or piece of jewellery.

Medical treatment often cannot wait.

That makes hospitals part of an essential-service industry where long-term demand is influenced by population growth, ageing, rising incomes, insurance penetration and increasing awareness of specialised healthcare.

ABH Healthcare Limited, which operates healthcare services under the Anil Baghi Hospital name, is now preparing to enter the stock market.

The ABH Healthcare IPO will open for subscription on August 24, 2026 and close on August 26. The company has fixed a price band of ₹96 to ₹102 per share and plans to raise approximately ₹34.98 crore through a fresh issue.

The shares are proposed to list on the NSE SME platform.

For investors, this IPO provides exposure to a regional hospital business that has developed capabilities across multiple medical specialties rather than concentrating on a single treatment category.

ABH Healthcare IPO Details

The IPO is effectively a capital-raising exercise for the company because the currently announced issue is a fresh issue rather than an OFS-dominated offering.

What Does ABH Healthcare Do?

ABH Healthcare operates Anil Baghi Hospital, a multispecialty healthcare facility in Firozpur, Punjab.

The hospital provides services across approximately 25 medical specialties.

Its medical capabilities cover areas including:

• Cardiac sciences
• Neurology
• Brain and spine procedures
• Gastroenterology
• Laparoscopic surgery
• Bariatric surgery
• Urology
• Pulmonology
• Nephrology
• ENT
• Maxillofacial surgery

The hospital has around 150 beds, giving it meaningful capacity within its regional healthcare market.

Why a Multispecialty Model Matters

A multispecialty hospital operates differently from a clinic focused on one treatment category.

Imagine a patient who first visits because of chest discomfort.

The hospital may need diagnostic services, cardiology consultation, imaging, laboratory testing and potentially surgery.

Another patient may require neurological treatment followed by rehabilitation.

Having several medical departments inside the same hospital allows ABH Healthcare to serve a broader range of patient requirements.

It can also create cross-referrals between departments.

This can improve utilisation of hospital infrastructure because operating theatres, diagnostic equipment, laboratories and beds can support multiple specialties.

Anil Baghi Hospital Has a Longer Healthcare Legacy

An interesting part of the ABH Healthcare story is that the corporate entity itself is comparatively young, but the hospital brand has a much longer operating history.

ABH Healthcare Limited was incorporated in March 2021, while Anil Baghi Hospital traces its establishment to 1985.

This distinction matters.

Investors are not evaluating a hospital that began treating patients only a few years ago.

The operating healthcare brand has existed for decades.

In hospital businesses, reputation can take years to build because patients and doctors often rely heavily on previous treatment experience and word-of-mouth recommendations.

Government Healthcare Schemes Expand Patient Access

One of the more important parts of ABH Healthcare's business model is its participation in government and institutional healthcare programmes.

The hospital provides services under arrangements and schemes involving organisations such as:

Ex-Servicemen Contributory Health Scheme (ECHS)

Indian Railways

Food Corporation of India

BSNL

and

Ayushman Bharat–Sarbat Sehat Bima Yojana.

It is also empanelled with multiple private and public health insurers and third-party administrators.

This can broaden the hospital's addressable patient population.

A patient does not necessarily need to pay the entire treatment cost directly from personal savings when eligible insurance or government coverage is available.

Insurance Penetration Can Support Hospital Demand

Healthcare affordability has historically been a major challenge in India.

Specialised surgery or prolonged hospitalisation can cost significantly more than an average household can comfortably pay.

Insurance changes those economics.

As more people receive coverage through government programmes, employers and private insurers, they can access organised healthcare facilities more easily.

For hospitals such as ABH, this creates a structural growth opportunity.

But insurance and government schemes can also create longer receivable cycles because payments may not arrive immediately after treatment.

ABH Has Built a Medical Workforce

As of FY2025, current IPO information indicates that ABH Healthcare had approximately 29 doctors and 137 nurses.

For a hospital, people are just as important as infrastructure.

An expensive operating theatre has limited value without experienced surgeons.

Advanced diagnostic equipment requires trained technicians.

Intensive-care capacity depends on doctors and nursing staff being available around the clock.

ABH's ability to retain and attract skilled healthcare professionals will therefore be critical to its future growth.

Doctor Reputation Can Drive Patient Volumes

Healthcare is heavily dependent on trust.

Patients often choose hospitals based on:

• Doctor reputation
• Previous treatment outcomes
• Family recommendations
• Availability of specialists
• Emergency capabilities
• Insurance acceptance
• Hospital infrastructure

A hospital can therefore build a strong local competitive position if experienced doctors remain associated with it.

However, this creates key-person risk.

If important specialists leave for competing hospitals, patient volumes in particular departments can be affected.

ABH Healthcare Has Shown Strong Historical Growth

The company's historical financial trajectory shows a meaningful improvement in operating scale.

Based on the restated IPO financial information, revenue increased from approximately:

₹29.61 crore in FY2023

to

₹41.38 crore in FY2024.

For the nine months ended December 2024, revenue was approximately ₹36.38 crore.

Annualising that nine-month period produces roughly ₹48.51 crore, although investors should remember that annualised figures are estimates rather than audited full-year results.

Profitability Has Improved Faster Than Revenue

The improvement in PAT is particularly notable.

ABH reported approximately:

*Annualised estimate based on nine-month performance.

This indicates that profitability expanded significantly faster than revenue during the latest disclosed period.

For investors, this raises an important question:

Is ABH reaching a scale where its hospital infrastructure is becoming more profitable?

Hospital Economics Improve With Occupancy

Hospitals have a large fixed-cost base.

Expenses continue even when some beds are empty.

A hospital still needs:

• Doctors
• Nurses
• Administrative staff
• Medical equipment
• Electricity
• Maintenance
• Emergency services
• Pharmacy infrastructure
• Laboratories

Once those costs are covered, additional patient volumes can improve operating leverage.

This means increasing bed occupancy and utilisation of expensive medical equipment can potentially improve margins faster than revenue.

ABH's recent profitability improvement may therefore become an important metric to monitor after listing.

EBITDA Margin Has Expanded

ABH's disclosed financial information shows a notable improvement in EBITDA margins.

The EBITDA margin was approximately:

13.64% in FY2023

16.65% in FY2024

and around

24.71% for the nine months ended December 2024.

The PAT margin for the latest nine-month period was approximately 9.13%.

This represents a substantial margin expansion.

Maintaining these margins as the business grows would strengthen the investment case.

However, hospital margins can fluctuate depending on patient mix, procedure mix, doctor costs and utilisation levels.

Return Ratios Have Also Strengthened

The latest available prospectus-based KPI information indicates:

The return on equity is attractive, but the debt-to-equity ratio immediately stands out.

Debt Is One of the Key Risks

ABH Healthcare has historically operated with significant borrowings relative to its equity base.

Total debt was approximately:

₹20.98 crore in FY2023

₹35.82 crore in FY2024

and

₹39.66 crore as of December 2024.

Net worth, meanwhile, stood at approximately ₹9.57 crore as of December 2024.

That explains the elevated debt-to-equity ratio.

For a hospital business, debt itself is not unusual because medical infrastructure requires substantial capital.

But leverage increases financial risk.

Interest payments continue even if patient volumes weaken.

Why Hospitals Require Large Capital Investment

Building healthcare capacity is expensive.

A hospital needs far more than beds and rooms.

Modern medical infrastructure can include:

• MRI and CT equipment
• Operating theatres
• Intensive-care equipment
• Ventilators
• Cardiac equipment
• Diagnostic laboratories
• Surgical systems
• Emergency facilities
• Medical-gas systems

Some equipment can cost crores of rupees.

Technology also changes, requiring hospitals to continually upgrade equipment.

This makes access to capital an important competitive advantage.

Fresh IPO Capital Can Strengthen the Business

ABH Healthcare's IPO is expected to raise approximately ₹34.98 crore through fresh equity shares.

Fresh equity can be particularly valuable for a leveraged hospital business.

Unlike debt, equity does not require fixed interest payments.

A stronger equity base can improve financial flexibility and provide additional resources for expansion and corporate requirements, depending on the final utilisation outlined in the offer documents.

For investors, the critical question after listing will be how efficiently the company converts new capital into additional earnings.

Firozpur Gives ABH a Different Market Position

ABH Healthcare operates from Firozpur in Punjab, rather than one of India's largest metropolitan healthcare markets.

This creates both opportunity and limitation.

The limitation is that the immediate addressable market is smaller than Mumbai, Delhi or Bengaluru.

But the opportunity is potentially lower organised-hospital competition compared with major cities.

Patients in regional markets increasingly expect advanced treatment closer to home.

They may prefer avoiding long journeys to major cities if comparable specialist treatment is available locally.

Tier-2 and Tier-3 Healthcare Is a Major Indian Opportunity

India's next phase of hospital expansion is not limited to metros.

Smaller cities need:

• Cardiac treatment
• Cancer care
• Neurology
• Dialysis
• Critical care
• Advanced surgery
• Diagnostics

As incomes and insurance penetration increase, demand for organised hospitals in regional markets can rise.

Hospitals with established local brands may benefit from this shift.

ABH Healthcare is positioned within that theme.

Medical Tourism Is Not the Only Healthcare Growth Story

When investors think about Indian hospitals, medical tourism often receives attention.

But ABH's opportunity is more local and regional.

Its growth can come from serving patients who might otherwise travel to larger cities for treatment.

That means success depends on building enough specialist capabilities to retain patients within its catchment area.

If the hospital can offer complex procedures locally, both patient volumes and average revenue per patient could potentially increase.

Government Schemes Can Drive Volume but Affect Cash Flow

Government-backed healthcare programmes can generate significant patient volumes.

However, they may also involve fixed package rates and payment delays.

That creates an important trade-off.

More scheme patients can improve bed utilisation.

But lower reimbursement rates can pressure margins.

Delayed payments can also increase receivables.

Investors should therefore monitor both revenue growth and operating cash flow.

Cash Flow Deserves Particular Attention

The company's restated cash-flow statement shows that trade receivables have historically absorbed working capital.

For the nine months ended December 2024, trade receivables increased by approximately ₹6.97 crore, creating a meaningful working-capital outflow.

This is important.

A hospital can report revenue when treatment is provided but receive the actual cash later from insurers, government schemes or institutional customers.

Fast profit growth is encouraging, but cash conversion ultimately determines financial strength.

Healthcare Quality Cannot Be Compromised for Growth

Hospitals operate in an industry where rapid expansion needs to be handled carefully.

Adding more patients without adding enough doctors, nurses and infrastructure can reduce service quality.

For ABH, growth after the IPO needs to remain balanced with:

• Clinical quality
• Patient safety
• Infection control
• Nursing standards
• Doctor availability
• Equipment maintenance

Healthcare businesses can suffer significant reputational damage if quality deteriorates.

Accreditation Builds Patient Confidence

The Anil Baghi Hospital material identifies the hospital as NABH accredited.

Accreditation can be useful because it provides an external framework around hospital processes and quality standards.

It can also matter when dealing with insurers, institutional customers and government healthcare programmes.

For a regional hospital competing for complex medical procedures, recognised quality standards can strengthen credibility.

Healthcare Demand Is Relatively Defensive

One attractive characteristic of hospital businesses is that healthcare demand does not disappear completely during economic slowdowns.

People may reduce discretionary purchases during difficult economic periods.

Medical emergencies still occur.

Chronic diseases still require treatment.

Surgeries may still be necessary.

This gives hospitals a somewhat defensive demand profile compared with many consumer businesses.

However, elective procedures can still be postponed, so the sector is not completely immune to economic conditions.

India's Disease Burden Supports Long-Term Demand

India faces increasing prevalence of lifestyle-related diseases such as:

• Diabetes
• Cardiovascular disease
• Obesity
• Kidney disease
• Hypertension

At the same time, the country's population is ageing.

These trends can increase long-term demand for specialised hospital services.

ABH's presence in cardiology, nephrology, neurology and bariatric care places it in medical categories where demand could remain structurally significant.

Competition Is Still a Major Risk

Healthcare can be attractive, but it is competitive.

ABH competes not only with local hospitals but also with larger hospitals in nearby cities.

Patients requiring major procedures may be willing to travel if they believe another hospital offers better specialists or technology.

ABH therefore needs to continually invest in:

Doctors + Technology + Infrastructure + Reputation.

A hospital cannot rely solely on historical brand recognition.

Skilled Healthcare Staff Are Expensive

India has shortages of specialised medical professionals in many regional markets.

Experienced doctors can command significant compensation.

Nurses and technicians also need to be recruited and retained.

As ABH expands, employee costs could increase.

If compensation rises faster than treatment pricing, margins may come under pressure.

The company's ability to retain its clinical team will therefore remain important.

SME IPO Liquidity Needs Consideration

ABH Healthcare is proposed to list on NSE SME rather than the mainboard.

SME shares can experience:

• Lower trading volumes
• Wider bid-ask spreads
• Higher volatility
• Reduced exit liquidity

Investors should therefore distinguish between business quality and stock liquidity.

A growing hospital does not automatically mean its shares will always be easy to buy or sell after listing.

ABH Healthcare GMP Today

As of August 19, 2026, there is no active Grey Market Premium reported for ABH Healthcare IPO.

The latest GMP tracker currently shows no quoted premium for August 17, August 18 or August 19.

This is important because the IPO does not open until August 24.

Grey-market activity may emerge closer to subscription.

Even if it does, GMP should be treated only as an unofficial sentiment indicator.

It is neither regulated nor a guaranteed prediction of the listing price.

Subscription Has Not Started

The ABH Healthcare IPO is still upcoming as of today.

Public bidding begins on Monday, August 24.

Therefore, there are currently no valid retail, NII or QIB subscription numbers.

The bidding period will run until August 26, followed by the expected allotment on August 27 and listing on August 31.

What Looks Positive in ABH Healthcare IPO?

ABH has several characteristics that deserve attention.

The Anil Baghi Hospital brand has a long operating history.

The company provides treatment across approximately 25 specialties.

It participates in government healthcare schemes and works with insurance providers.

Revenue has expanded historically.

Profitability and EBITDA margins have improved significantly.

Demand for organised regional healthcare also has a strong structural growth argument.

Most importantly, the IPO is raising fresh capital for the company rather than being structured primarily as an exit for existing shareholders.

What Requires Caution?

The balance sheet is the most obvious area requiring attention.

Historical borrowings are high relative to net worth.

The business also depends heavily on doctors and trained healthcare professionals.

Government and insurance receivables can affect cash flow.

Medical equipment requires continuing capital investment.

ABH remains concentrated around a regional hospital operation.

And because this is an NSE SME listing, post-listing liquidity may be lower than in a mainboard IPO.

Investors should therefore look beyond recent PAT growth.

What Should Investors Monitor After Listing?

For ABH Healthcare, some of the most useful post-IPO indicators will be:

• Patient volumes
• Bed occupancy
• Revenue per occupied bed
• Revenue growth
• EBITDA margin
• PAT margin
• Doctor additions
• New medical specialties
• Insurance and government-scheme mix
• Receivable days
• Operating cash flow
• Borrowings
• Debt-to-equity
• Return on capital

Debt reduction and operating cash flow deserve particular attention.

If profits continue growing while leverage falls and cash generation improves, the company's financial profile could strengthen substantially.

Final View on ABH Healthcare IPO

The ABH Healthcare IPO opens on August 24, 2026, at a price band of ₹96–₹102 per share and aims to raise approximately ₹34.98 crore through a fresh issue, with proposed NSE SME listing on August 31.

The investment story is based on more than simply adding hospital beds.

ABH Healthcare is attempting to build on the long-standing Anil Baghi Hospital brand and expand an integrated regional healthcare platform covering approximately 25 specialties.

Historical financial improvement is encouraging. Revenue increased from approximately ₹29.61 crore in FY2023 to ₹41.38 crore in FY2024, while PAT increased from around ₹0.71 crore to ₹1.65 crore. For the nine months ended December 2024, PAT had already reached approximately ₹3.32 crore, alongside a significant improvement in EBITDA margins.

The opportunity is clear: demand for quality healthcare outside India's biggest metros continues to expand, while government insurance programmes and increasing private insurance penetration can bring more patients into organised hospitals.

The challenge is equally important.

ABH needs to manage its relatively high leverage, improve cash conversion, retain skilled doctors and nurses, maintain clinical standards and use IPO capital efficiently.

For long-term investors, the key question is therefore not whether ABH Healthcare receives an immediate listing premium.